• Overview 2003 available upon request.
• Overview 2002 coming soon on-line.
• Overview 2001 see summary below.

The total Ukrainian pharmaceutical market reached 571.8 mln. USD in year 2001 that shown a 23.8% growth from previous year. The growth resulted from an increase of both imported and locally manufactured pharmaceutical products.

Trends of 2000 and 2001 show more or less stable situation in shares of import, export and locally manufactured pharmaceutical products with slight increase in import and little decrease of export (which is mainly oriented to Russian market) in year 2001

Ukrainian manufacturers operate in the lowest price segment of the market, supplying mainly generics, branded generics and vitamins. In 2001 local pharmaceutical production grew by 21.4%. Locally produced pharmaceuticals constituted 43.9% of the total pharmaceutical market, while import accounted for 56.1%.Ukrainian pharmaceutical industry manufactures approximately 1,300 medicines. The largest local producers are: Darnytsa (Kiev), Kyivmedpreparat (Kiev), Pharmak (Kiev), Borshchahivsky Chemical and Pharmaceutical Plant (Kiev); Indar (Kiev), Stryrol (Donetsk); Zdoroviye (Kharkiv); Biostimulator (Odessa), Halychpharm (Lviv).
Ukraine is second in the CIS after Russia in the number of enterprises in the pharmaceutical sector reached 160 manufacturing companies, 85% of all Ukrainian pharmaceuticals produced by 22 of them. Major part of those companies has been privatized, and only seven are still state owned.

Total number of retail pharmacies in Ukraine is 11460 and they are divided by ownership type into three categories: Private, which covers almost 10% of all pharmacies, state, which is nearly 48 % from all of them and joint-stock companies - 42%. Ukrainian state statistics gives us an average of one pharmacy turnover that equals to 40 thousand USD a year. Certainly, those figures vary significantly between pharmacies of different ownership types as well as very much depends from the region where pharmacy is situated.

Tendency of creation of the pharmacy chains reflected on all regions but the most productive in their business are Central and Eastern regions due to higher density of the population and industry there. Biggest pharmacy chains are situated mainly in Eastern and Central regions that also correspond to main locations of the top pharmaceutical distributors.

Obviously, prices on the locally manufactured generic products are much cheaper than those in the UK and in other European countries. While for branded products prices are nearly same or higher than basic UK prices.